Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease.

Authors :: Bonig H
Verbeek M
Herhaus P
Braitsch K
Beutel G
Schmid C
Müller N
Bug G
Döring M
von Stackelberg A
Tischer J
Ayuk F
Wulf G
Holtick U
Pfeffermann LM
Jahrsdörfer B
Schrezenmeier H
Kuci S
Kuci Z
Zens A
Tribanek M
Zeiser R
Huenecke S
Bader P
Source :: Journal of translational medicine [J Transl Med] 2024 Jun 13; Vol. 22 (1), pp. 566. Date of Electronic Publication: 2024 Jun 13.
Publication Year :: 2024

Full Text Access

Tools